KH Domain Containing, RNA Binding, Signal Transduction Associated 3 (KHDRBS3) Peptide
KHDRBS3
Reactivity: Mammalian
Host: Synthetic
BP, WB, IHC
Catalog No. ABIN938066
$398.38
Plus shipping costs $50.00
100 μg
Shipping to:
United States
Delivery in 16 to 22 Business Days
Quick Overview for KH Domain Containing, RNA Binding, Signal Transduction Associated 3 (KHDRBS3) Peptide (ABIN938066)
Target
KHDRBS3
(KH Domain Containing, RNA Binding, Signal Transduction Associated 3 (KHDRBS3))
Origin
Mammalian
Source
Synthetic
Application
Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
-
-
Peptide Type
- Synthetic
-
Sequence
- EQSYDSYDNS YSTPAQSGAD YYDYGHGLSE ETYDSYGQEE WTNSRHKAPS
-
Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of KHDRBS3 antibody,
Alternative Names: KHDRBS3 control peptide, KHDRBS3 antibody Blocking Peptide, Anti-KHDRBS3 Blocking Peptide, Kh Domain Containing Rna Binding Signal Transduction Associated 3 Blocking Peptide, KHDRBS3, KHDRBS-3, KHDRBS 3, KHDRBS-3 Blocking Peptide, KHDRBS 3 Blocking Peptide
-
-
-
-
Application Notes
- Optimal conditions should be determined by the investigator
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
-
Buffer
- PBS
-
Handling Advice
- Avoid repeated freeze/thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20 °C long term.
-
-
- KHDRBS3 (KH Domain Containing, RNA Binding, Signal Transduction Associated 3 (KHDRBS3))
-
Background
- As a RNA-binding protein, KHDRBS3 plays a role in the regulation of alternative splicing and influences mRNA splice site selection and exon inclusion. KHDRBS3 may play a role as a negative regulator of cell growth. It inhibits cell proliferation and involved in splice site selection of vascular endothelial growth factor. It induces an increased concentration-dependent incorporation of exon in CD44 pre-mRNA by direct binding to purine-rich exonic enhancer. RNA-binding abilities are down-regulated by tyrosine kinase PTK6. It also involved in post-transcriptional regulation of HIV-1 gene expression.
-
Molecular Weight
- 38 kDa
Target
-
You are here:
